Stryker Knees — Net Sales decreased by 1.9% to $1.26B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $1.14B to $1.26B. Over 3 years (FY 2021 to FY 2024), Knees — Net Sales shows an upward trend with a 9.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong demand for orthopedic procedures and successful market penetration of the company's knee implant portfolio, while a decrease may signal increased competition, pricing pressure, or a slowdown in elective surgical volumes.
This metric represents the total revenue generated from the sale of knee replacement implants, instrumentation, and rela...
Comparable to knee reconstruction revenue reported by major medical device competitors like Zimmer Biomet or Smith & Nephew, reflecting overall orthopedic market health.
syk_segment_knees_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $948.00M | $878.00M | $1.05B | $928.00M | $1.00B | $962.00M | $1.10B | $1.13B | $1.12B | $1.03B | $1.26B | $1.18B | $1.20B | $1.14B | $1.37B | $1.28B | $1.28B | $1.26B |
| QoQ Change | — | -7.4% | +19.1% | -11.3% | +7.8% | -3.8% | +14.8% | +2.5% | -0.7% | -8.4% | +22.3% | -6.7% | +2.4% | -5.3% | +20.5% | -7.0% | +0.2% | -1.9% |
| YoY Change | — | — | — | — | +5.5% | +9.6% | +5.5% | +22.0% | +12.4% | +7.1% | +14.1% | +3.9% | +7.1% | +10.7% | +9.0% | +8.7% | +6.3% | +10.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.